Singalavanija Srisupalak, Limpongsanurak Wanida
Dermatology Unit, Queen Sirikit National Institute of Child Health, College of Medicine, Rangsit University, Bangkok, Thailand.
J Med Assoc Thai. 2008 Oct;91 Suppl 3:S143-6.
Mastocytosis is a disorder of mast cells proliferation within various organs, most commonly in the skin. The disease more commonly appears during infancy than adult.
To characterize the clinical features, response to therapy and prognosis of cutaneous mastocytosis in children.
A retrospective study of cutaneous mastocytosis was performed at Queen Sirikit National Institute of Child Health during January 1994 to December 2007.All cases were confirmed by histological diagnosis.
There were a total of 50 patients. The male to female ratio was 1:1.2. Age at onset of lesions ranged from birth to 7 years. Forty-seven patients (94%) developed skin lesions within the first year of ife. There were 45 cases (90%) of urticaria pigmentosa, 3 cases (6%) of mastocytoma and 2 cases (4%) of diffuse cutaneous mastocytosis. None of the patient had a family history of cutaneous mastocytosis. Most of the children were healthy, except the one who had germ cell ovarian tumor Skin biopsies were performed in all cases and revealed mast cells infiltrate in the dermis. Treatment included oral antihistamine in all cases. Oral mast cell stabilizers were given in 6 patients (12%) and topical corticosteroids in 15 patients (30%). Four patients (8%) were treated with oral prednisolone. The skin lesions resolved only in 1 patient (2%) at age 7.8 years, the others still had skin lesions without systemic symptoms.
Cutaneous mastocytosis is a benign disease in children without systemic involvement.
肥大细胞增多症是一种各种器官内肥大细胞增殖的疾病,最常见于皮肤。该疾病在婴儿期比成人期更常见。
描述儿童皮肤肥大细胞增多症的临床特征、治疗反应及预后。
1994年1月至2007年12月在诗丽吉王后国家儿童健康研究所对皮肤肥大细胞增多症进行了一项回顾性研究。所有病例均经组织学诊断确诊。
共有50例患者。男女比例为1:1.2。皮损出现的年龄范围从出生到7岁。47例(94%)在生命的第一年内出现皮肤病变。有45例(90%)为色素性荨麻疹,3例(6%)为肥大细胞瘤,2例(4%)为弥漫性皮肤肥大细胞增多症。所有患者均无皮肤肥大细胞增多症家族史。大多数儿童身体健康,除了一名患有生殖细胞卵巢肿瘤的儿童。所有病例均进行了皮肤活检,显示真皮中有肥大细胞浸润。治疗包括所有病例均给予口服抗组胺药。6例患者(12%)给予口服肥大细胞稳定剂,15例患者(30%)给予外用皮质类固醇。4例患者(8%)接受口服泼尼松龙治疗。仅1例患者(2%)在7.8岁时皮肤病变消退,其他患者仍有皮肤病变但无全身症状。
儿童皮肤肥大细胞增多症是一种无全身受累的良性疾病。